BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 16621190)

  • 21. Intranasal administration of CpG oligonucleotides induces mucosal and systemic Type 1 immune responses and adjuvant activity to porcine reproductive and respiratory syndrome killed virus vaccine in piglets in vivo.
    Zhang L; Tian X; Zhou F
    Int Immunopharmacol; 2007 Dec; 7(13):1732-40. PubMed ID: 17996683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of IL-6 and TNF-alpha as molecular adjuvants on immune responses to FMDV and maturation of dendritic cells by DNA vaccination.
    Su B; Wang J; Wang X; Jin H; Zhao G; Ding Z; Kang Y; Wang B
    Vaccine; 2008 Sep; 26(40):5111-22. PubMed ID: 18462845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced protective efficacy and reduced viral load of foot-and-mouth disease DNA vaccine with co-stimulatory molecules as the molecular adjuvants.
    Xiao C; Jin H; Hu Y; Kang Y; Wang J; Du X; Yang Y; She R; Wang B
    Antiviral Res; 2007 Oct; 76(1):11-20. PubMed ID: 17540462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-administration of polyphosphazenes with CpG oligodeoxynucleotides strongly enhances immune responses in mice immunized with Hepatitis B virus surface antigen.
    Mutwiri G; Benjamin P; Soita H; Babiuk LA
    Vaccine; 2008 May; 26(22):2680-8. PubMed ID: 18430493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancement of mucosal immune responses by intranasal co-delivery of Newcastle disease vaccine plus CpG oligonucleotide in SPF chickens in vivo.
    Zhang L; Zhang M; Li J; Cao T; Tian X; Zhou F
    Res Vet Sci; 2008 Dec; 85(3):495-502. PubMed ID: 18359498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone marrow dendritic cells internalize live RF-81 bovine rotavirus and rotavirus-like particles (RF 2/6-GFP-VLP and RF 8*2/6/7-VLP) but are only activated by live bovine rotavirus.
    Istrate C; Douagi I; Charpilienne A; McInerney GM; Hidmark A; Johansen K; Larsson M; Magnusson KE; Poncet D; Svensson L; Hinkula J
    Scand J Immunol; 2007 Jun; 65(6):494-502. PubMed ID: 17523941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains.
    LoBue AD; Lindesmith L; Yount B; Harrington PR; Thompson JM; Johnston RE; Moe CL; Baric RS
    Vaccine; 2006 Jun; 24(24):5220-34. PubMed ID: 16650512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distribution and phenotype of murine rotavirus-specific B cells induced by intranasal immunization with 2/6 virus-like particles.
    Ogier A; Franco MA; Charpilienne A; Cohen J; Pothier P; Kohli E
    Eur J Immunol; 2005 Jul; 35(7):2122-30. PubMed ID: 15948217
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vaccination with porcine reproductive and respiratory syndrome killed virus vaccine and immunostimulatory oligodeoxynucleotides induces specific immunity in piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Vaccine; 2007 Feb; 25(10):1735-42. PubMed ID: 17229497
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Der p 1 peptide on virus-like particles is safe and highly immunogenic in healthy adults.
    Kündig TM; Senti G; Schnetzler G; Wolf C; Prinz Vavricka BM; Fulurija A; Hennecke F; Sladko K; Jennings GT; Bachmann MF
    J Allergy Clin Immunol; 2006 Jun; 117(6):1470-6. PubMed ID: 16751015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PIKA as an adjuvant enhances specific humoral and cellular immune responses following the vaccination of mice with HBsAg plus PIKA.
    Shen E; Li L; Li L; Feng L; Lu L; Yao Z; Lin H; Wu C
    Cell Mol Immunol; 2007 Apr; 4(2):113-20. PubMed ID: 17484805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant viral-like particles of parvovirus B19 as antigen carriers of anthrax protective antigen.
    Ogasawara Y; Amexis G; Yamaguchi H; Kajigaya S; Leppla SH; Young NS
    In Vivo; 2006; 20(3):319-24. PubMed ID: 16724664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High immunogenicity of a hydrophilic component of the hepatitis B virus preS1 sequence exposed on the surface of three virus-like particle carriers.
    Skrastina D; Bulavaite A; Sominskaya I; Kovalevska L; Ose V; Priede D; Pumpens P; Sasnauskas K
    Vaccine; 2008 Apr; 26(16):1972-81. PubMed ID: 18343539
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of interferon-gamma during CpG oligodeoxynucleotide-adjuvanted immunization with recombinant proteins.
    Rosa DS; Bastos KR; Bargieri DY; Tzelepis F; Nomizo A; Russo M; Soares IS; Rodrigues MM
    Vaccine; 2007 Aug; 25(32):6007-17. PubMed ID: 17629370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screen of multifunctional monoclonal antibodies against hepatitis B core virus-like particles.
    Sun C; Ding FX; Wang F; He XW; He Y; Li ZS; Sun SH
    Microbiol Immunol; 2009 Jun; 53(6):340-8. PubMed ID: 19493202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes.
    McBurney SP; Young KR; Ross TM
    Virology; 2007 Feb; 358(2):334-46. PubMed ID: 17011011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
    Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
    Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethanol consumption modifies dendritic cell antigen presentation in mice.
    Heinz R; Waltenbaugh C
    Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus.
    Näslund J; Lagerqvist N; Habjan M; Lundkvist A; Evander M; Ahlm C; Weber F; Bucht G
    Virology; 2009 Mar; 385(2):409-15. PubMed ID: 19157482
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.